- Home
- WAVE vs TENX Comparison
WAVE vs TENX Comparison
Compare WAVE & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- TENX
- Stock Information
- Founded
- WAVE 2011
- TENX 1967
- Country
- WAVE Israel
- TENX United States
- Employees
- WAVE N/A
- TENX N/A
- Industry
- WAVE Electric Utilities: Central
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- WAVE Utilities
- TENX Health Care
- Exchange
- WAVE Nasdaq
- TENX Nasdaq
- Market Cap
- WAVE 13.9M
- TENX 11.4M
- IPO Year
- WAVE 2021
- TENX N/A
- Fundamental
- Price
- WAVE $5.68
- TENX $3.40
- Analyst Decision
- WAVE
- TENX Strong Buy
- Analyst Count
- WAVE 0
- TENX 2
- Target Price
- WAVE N/A
- TENX $30.00
- AVG Volume (30 Days)
- WAVE 30.0K
- TENX 27.5K
- Earning Date
- WAVE 11-29-2024
- TENX 11-11-2024
- Dividend Yield
- WAVE N/A
- TENX N/A
- EPS Growth
- WAVE N/A
- TENX N/A
- EPS
- WAVE N/A
- TENX N/A
- Revenue
- WAVE $306,000.00
- TENX N/A
- Revenue This Year
- WAVE N/A
- TENX N/A
- Revenue Next Year
- WAVE N/A
- TENX N/A
- P/E Ratio
- WAVE N/A
- TENX N/A
- Revenue Growth
- WAVE 1076.92
- TENX N/A
- 52 Week Low
- WAVE $1.01
- TENX $2.77
- 52 Week High
- WAVE $6.60
- TENX $61.20
- Technical
- Relative Strength Index (RSI)
- WAVE 64.45
- TENX 42.55
- Support Level
- WAVE $4.65
- TENX $3.28
- Resistance Level
- WAVE $5.88
- TENX $3.54
- Average True Range (ATR)
- WAVE 0.78
- TENX 0.20
- MACD
- WAVE 0.08
- TENX -0.01
- Stochastic Oscillator
- WAVE 71.63
- TENX 26.42
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.